Cephagenix
Latest round
- Seed
Last raised
- Jan 2025
Total raised
- $9.3M
Investors
- 2
About Cephagenix
, is a biotechnology company focused on developing innovative migraine treatments, aiming to improve patient outcomes through advanced therapeutic agents targeting migraine mechanisms. The firm specializes in creating first-in-class KATP channel inhibitors, aiming to provide safe and effective options for migraine relief. The revenue model for Cephagenix is structured around partnerships with healthcare providers and pharmaceutical distributors, ensuring a steady flow of products to various markets. Transactions typically occur through direct sales to clinics and hospitals, as well as through retail channels where their products can be purchased by consumers. The company plans to use the January 2025 funds to enhance its product line with new migraine therapies, aiming for market launch in the upcoming years. Cephagenix is also pursuing expansion into additional European markets and North America, with specific regions targeted for late 2025.
Who invested in Cephagenix
2 investors across 1 round
See all investors in Cephagenix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 15, 2025
Amount
$9.3M
Investors
Questions about Cephagenix
Who invested in Cephagenix?
Cephagenix has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cephagenix raised?
Cephagenix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cephagenix last raise money?
Cephagenix's most recent round on record is a Seed, in Jan 2025.
What does Cephagenix do?
, is a biotechnology company focused on developing innovative migraine treatments, aiming to improve patient outcomes through advanced therapeutic agents targeting migraine mechanisms.
Where is Cephagenix headquartered?
Cephagenix is headquartered in Glostrup, Denmark.
Which VCs invest in companies like Cephagenix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at Cephagenix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Cephagenix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.